Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.

Identifieur interne : 000858 ( PubMed/Checkpoint ); précédent : 000857; suivant : 000859

Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.

Auteurs : N K Ayisi [Ghana] ; S V Gupta ; L F Qualtiere

Source :

RBID : pubmed:1664434

Descripteurs français

English descriptors

Abstract

A modified tetrazolium-based colorimetric assay was used to determine the anti-HIV activities of ddAzThd, ddCyd, ddIno, and PFA. In this assay, poly-1-lysine-coated plates were used to attach the MT-2 cells to the bottom of the plates. A fixed amount of virus (50 TCID50) was used in each well. A modified version of the formula published by Pauwels et al. (1988) was used for calculating the percentage cell protection from virus infection. Using CC10/EC90 to calculate the selective indices, the decreasing order of selectivity against HIV-1 strain A87SF, was: ddAzThd greater than PFA greater than ddCyd greater than ddIno. Against HIV-1 strain A79SK-1 the decreasing order of selectivity was: PFA greater than ddIno greater than AzThd greater than ddCyd. The modified formula showed lack of anti-HIV activity for thymidine at non-toxic concentrations.

PubMed: 1664434


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:1664434

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.</title>
<author>
<name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation>
<orgName type="university">Université du Ghana</orgName>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gupta, S V" sort="Gupta, S V" uniqKey="Gupta S" first="S V" last="Gupta">S V Gupta</name>
</author>
<author>
<name sortKey="Qualtiere, L F" sort="Qualtiere, L F" uniqKey="Qualtiere L" first="L F" last="Qualtiere">L F Qualtiere</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1664434</idno>
<idno type="pmid">1664434</idno>
<idno type="wicri:Area/PubMed/Corpus">000876</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000876</idno>
<idno type="wicri:Area/PubMed/Curation">000875</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000875</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000875</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000875</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.</title>
<author>
<name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
<affiliation wicri:level="4">
<nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation>
<orgName type="university">Université du Ghana</orgName>
<country>Ghana</country>
<placeName>
<settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gupta, S V" sort="Gupta, S V" uniqKey="Gupta S" first="S V" last="Gupta">S V Gupta</name>
</author>
<author>
<name sortKey="Qualtiere, L F" sort="Qualtiere, L F" uniqKey="Qualtiere L" first="L F" last="Qualtiere">L F Qualtiere</name>
</author>
</analytic>
<series>
<title level="j">Journal of virological methods</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Colorimetry (methods)</term>
<term>Didanosine (pharmacology)</term>
<term>Foscarnet</term>
<term>HIV-1 (drug effects)</term>
<term>Humans</term>
<term>Phosphonoacetic Acid (analogs & derivatives)</term>
<term>Phosphonoacetic Acid (pharmacology)</term>
<term>Tetrazolium Salts</term>
<term>Thymidine (pharmacology)</term>
<term>Zalcitabine (pharmacology)</term>
<term>Zidovudine (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide phosphono-acétique (analogues et dérivés)</term>
<term>Acide phosphono-acétique (pharmacologie)</term>
<term>Antiviraux (pharmacologie)</term>
<term>Colorimétrie ()</term>
<term>Didéoxyinosine (pharmacologie)</term>
<term>Foscarnet</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Sels de tétrazolium</term>
<term>Thymidine (pharmacologie)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) ()</term>
<term>Zalcitabine (pharmacologie)</term>
<term>Zidovudine (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Phosphonoacetic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
<term>Didanosine</term>
<term>Phosphonoacetic Acid</term>
<term>Thymidine</term>
<term>Zalcitabine</term>
<term>Zidovudine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Acide phosphono-acétique</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>HIV-1</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Colorimetry</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Acide phosphono-acétique</term>
<term>Antiviraux</term>
<term>Didéoxyinosine</term>
<term>Thymidine</term>
<term>Zalcitabine</term>
<term>Zidovudine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Foscarnet</term>
<term>Humans</term>
<term>Tetrazolium Salts</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Colorimétrie</term>
<term>Foscarnet</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Sels de tétrazolium</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A modified tetrazolium-based colorimetric assay was used to determine the anti-HIV activities of ddAzThd, ddCyd, ddIno, and PFA. In this assay, poly-1-lysine-coated plates were used to attach the MT-2 cells to the bottom of the plates. A fixed amount of virus (50 TCID50) was used in each well. A modified version of the formula published by Pauwels et al. (1988) was used for calculating the percentage cell protection from virus infection. Using CC10/EC90 to calculate the selective indices, the decreasing order of selectivity against HIV-1 strain A87SF, was: ddAzThd greater than PFA greater than ddCyd greater than ddIno. Against HIV-1 strain A79SK-1 the decreasing order of selectivity was: PFA greater than ddIno greater than AzThd greater than ddCyd. The modified formula showed lack of anti-HIV activity for thymidine at non-toxic concentrations.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">1664434</PMID>
<DateCreated>
<Year>1992</Year>
<Month>03</Month>
<Day>19</Day>
</DateCreated>
<DateCompleted>
<Year>1992</Year>
<Month>03</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0166-0934</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>33</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1991</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virological methods</Title>
<ISOAbbreviation>J. Virol. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.</ArticleTitle>
<Pagination>
<MedlinePgn>335-44</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A modified tetrazolium-based colorimetric assay was used to determine the anti-HIV activities of ddAzThd, ddCyd, ddIno, and PFA. In this assay, poly-1-lysine-coated plates were used to attach the MT-2 cells to the bottom of the plates. A fixed amount of virus (50 TCID50) was used in each well. A modified version of the formula published by Pauwels et al. (1988) was used for calculating the percentage cell protection from virus infection. Using CC10/EC90 to calculate the selective indices, the decreasing order of selectivity against HIV-1 strain A87SF, was: ddAzThd greater than PFA greater than ddCyd greater than ddIno. Against HIV-1 strain A79SK-1 the decreasing order of selectivity was: PFA greater than ddIno greater than AzThd greater than ddCyd. The modified formula showed lack of anti-HIV activity for thymidine at non-toxic concentrations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ayisi</LastName>
<ForeName>N K</ForeName>
<Initials>NK</Initials>
<AffiliationInfo>
<Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>S V</ForeName>
<Initials>SV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Qualtiere</LastName>
<ForeName>L F</ForeName>
<Initials>LF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Virol Methods</MedlineTA>
<NlmUniqueID>8005839</NlmUniqueID>
<ISSNLinking>0166-0934</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013778">Tetrazolium Salts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>364P9RVW4X</RegistryNumber>
<NameOfSubstance UI="D017245">Foscarnet</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4B9XT59T7S</RegistryNumber>
<NameOfSubstance UI="D015215">Zidovudine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6L3XT8CB3I</RegistryNumber>
<NameOfSubstance UI="D016047">Zalcitabine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K3GDH6OH08</RegistryNumber>
<NameOfSubstance UI="D016049">Didanosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>N919E46723</RegistryNumber>
<NameOfSubstance UI="D010746">Phosphonoacetic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VC2W18DGKR</RegistryNumber>
<NameOfSubstance UI="D013936">Thymidine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003124" MajorTopicYN="N">Colorimetry</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016049" MajorTopicYN="N">Didanosine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017245" MajorTopicYN="N">Foscarnet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010746" MajorTopicYN="N">Phosphonoacetic Acid</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013778" MajorTopicYN="Y">Tetrazolium Salts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013936" MajorTopicYN="N">Thymidine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016047" MajorTopicYN="N">Zalcitabine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015215" MajorTopicYN="N">Zidovudine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1991</Year>
<Month>8</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1991</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1991</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1664434</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Ghana</li>
</country>
<region>
<li>Région du Grand Accra</li>
</region>
<settlement>
<li>Accra</li>
<li>Legon (Ghana)</li>
</settlement>
<orgName>
<li>Université du Ghana</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Gupta, S V" sort="Gupta, S V" uniqKey="Gupta S" first="S V" last="Gupta">S V Gupta</name>
<name sortKey="Qualtiere, L F" sort="Qualtiere, L F" uniqKey="Qualtiere L" first="L F" last="Qualtiere">L F Qualtiere</name>
</noCountry>
<country name="Ghana">
<region name="Région du Grand Accra">
<name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000858 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000858 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:1664434
   |texte=   Modified tetrazolium-based colorimetric method for determining the activities of anti-HIV compounds.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:1664434" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024